International Open Access Journal Platform

Exploration of Environmental Responsibility and Green Transformation Paths in Pharmaceutical Quality Control—A Case Study of Quality Control Positions in Taiji Group

Environment and Resource / 2025,7(1): 275-287 / 2025-10-20 28 10

View Download PDF

• Authors: Guo Shi Junzhao Ma Chenli Liu
• Information:

  Taiji Group Chongqing Fuling Pharmaceutical Factory Co., Ltd.Fuling District, Chongqing

• Keywords:
  Pharmaceutical quality control; Green analytical methods; Environmental responsibility; Taiji Group; Green transformation
• Abstract: Against the backdrop of the advancing “dual-carbon” strategy, pharmaceutical quality control, as a key link in ensuring drug safety, also bears significant environmental responsibilities and the mission of green transformation. This paper takes Taiji Group as a case study to systematically explore the practical paths and effectiveness of its quality control positions in green transformation. By identifying environmental load points in pharmaceutical quality control—such as solvent pollution, waste liquid discharge, high energy consumption, and experimental consumables—this study constructs a green indicator system, promotes green method substitution, embeds ESG responsibilities in positions, and builds a digital quality control platform, aiming to explore a feasible mechanism for the coordinated development of “precision testing” and “green low-carbon.” The research finds that Taiji Group has significantly reduced the carbon footprint of testing and the discharge of “three wastes” through technical means such as green solvent substitution, aqueous chromatography, near-infrared spectroscopy, and SFC; achieved green visualization and performance evaluation of the entire testing process through the integration of LIMS and MES systems; and formed a trinity green management model of “system + technology + awareness” through closed-loop waste management and green behavior score assessment. This paper provides enterprise practice samples and policy recommendation support for constructing a green pharmaceutical quality control system, and has practical significance for promoting the coordinated development of high-quality and greenization in the pharmaceutical industry.
• DOI: https://doi.org/10.35534/er.0701021
• Cite: Shi, G., Ma, J.,Z., Liu, C., L. (2025). Exploration of Environmental Responsibility and Green Transformation Paths in Pharmaceutical Quality Control—A Case Study of Quality Control Positions in Taiji Group. Environment and Resource, 7(1), 275-287.